| 2 min read
For the first time, researchers imaged a human protein essential to the RNA interference process and found ways to design better siRNA drugs.
| 3 min read
Patient advocates warn that political momentum to reduce animal testing is outpacing the scientific validation of alternative methods.
| 5 min read
Therapeutic cancer vaccines are being reengineered to deliver stronger immune activation and longer-lasting protection against disease recurrence.News
| 5 min read
New population-level data reveal unprecedented declines in cervical cancer among vaccinated cohorts, even as vaccination rates begin to slip in some countries.
| 5 min read
The approach identifies entirely new chemical structures that could help replenish a thinning antibiotic pipeline as resistance continues to rise.
| 4 min read
Phase 3 trial results for neurological drugs, an AI platform for central nervous system drug discovery, a novel long-acting flu antiviral, and more led the news this week.
| 3 min read
Dehydrodolichyl diphosphate synthase (DHDSS)-related disease has no available treatments. The new work could finally change that with nicotinamide mononucleotide (NMN).
| 4 min read
Sessions spanning chemoproteomics, AI-driven proteomics, biotherapeutic characterization, single-cell omics, and spatial multiomics all pointed toward mass spectrometry’s growing role in drug discovery and development.
| 2 min read
The fully-automated system can complete a full drug discovery cycle in a matter of hours rather than weeks.
| 4 min read
New instrument launches from two major vendors at this year's conference reflected shared priorities: higher proteome coverage, richer characterization of complex biotherapeutics, and tighter integration of AI.
| 6 min read
By stabilizing G-quadruplex DNA, a revived anticancer drug offers a new way to shut down a key oncogene.
| 3 min read
Some people with amyloid plaques and tau tangles in their brain never develop Alzheimer’s disease. New research suggests it comes down to microglial activity.
